APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Reliever (Rescue) Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Asthma Reliever (Rescue) Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchAsthma Reliever (Rescue) Medications Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Reliever (Rescue) Medications Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Asthma Reliever (Rescue) Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Reliever (Rescue) Medications Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Reliever (Rescue) Medications Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Asthma Reliever (Rescue) Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Reliever (Rescue) Medications include AstraZeneca plc, Dulera, Genentech Inc, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, QVAR, Roche Holdings Ltd and Sanofi-Aventis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Reliever (Rescue) Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Reliever (Rescue) Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Reliever (Rescue) Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Reliever (Rescue) Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Reliever (Rescue) Medications Segment by Company

AstraZeneca plc

Dulera

Genentech Inc

Glaxosmithkline plc

MAP Pharmaceuticals，Inc

Merck & Co. Inc

QVAR

Roche Holdings Ltd

Sanofi-Aventis

Schering-Plough Corp

Sepracor, Inc

Theravance Inc

Asthma Reliever (Rescue) Medications Segment by Type

Quick-Relief Medications

Long-Term Control Medications

Asthma Reliever (Rescue) Medications Segment by Application

Adult

Children

Adolescent

Asthma Reliever (Rescue) Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Reliever (Rescue) Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Reliever (Rescue) Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Reliever (Rescue) Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Reliever (Rescue) Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Reliever (Rescue) Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Asthma Reliever (Rescue) Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Asthma Reliever (Rescue) Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Asthma Reliever (Rescue) Medications Industry Trends Table 2. Asthma Reliever (Rescue) Medications Industry Drivers Table 3. Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges Table 4. Asthma Reliever (Rescue) Medications Industry Restraints Table 5. Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Asthma Reliever (Rescue) Medications Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers Table 9. Global Asthma Reliever (Rescue) Medications Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Asthma Reliever (Rescue) Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Asthma Reliever (Rescue) Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Asthma Reliever (Rescue) Medications Manufacturers, Product Type & Application Table 13. Global Asthma Reliever (Rescue) Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Reliever (Rescue) Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Quick-Relief Medications Table 17. Major Manufacturers of Long-Term Control Medications Table 18. Global Asthma Reliever (Rescue) Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 20. Global Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 21. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2026) Table 22. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2027-2032) Table 23. Global Asthma Reliever (Rescue) Medications Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (K Units) Table 25. Global Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (K Units) Table 26. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2026) Table 27. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Table 29. Major Manufacturers of Children Table 30. Major Manufacturers of Adolescent Table 31. Global Asthma Reliever (Rescue) Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 33. Global Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 34. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2026) Table 35. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2027-2032) Table 36. Global Asthma Reliever (Rescue) Medications Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (K Units) Table 38. Global Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (K Units) Table 39. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2026) Table 40. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2027-2032) Table 41. Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2026) & (K Units) Table 43. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2021-2026) Table 44. Global Asthma Reliever (Rescue) Medications Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Asthma Reliever (Rescue) Medications Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 48. North America Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 49. Europe Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 51. Europe Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 58. Global Asthma Reliever (Rescue) Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Asthma Reliever (Rescue) Medications Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Asthma Reliever (Rescue) Medications Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2021-2026) Table 62. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2027-2032) Table 63. AstraZeneca plc Company Information Table 64. AstraZeneca plc Business Overview Table 65. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio Table 67. AstraZeneca plc Recent Development Table 68. Dulera Company Information Table 69. Dulera Business Overview Table 70. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Dulera Asthma Reliever (Rescue) Medications Product Portfolio Table 72. Dulera Recent Development Table 73. Genentech Inc Company Information Table 74. Genentech Inc Business Overview Table 75. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 77. Genentech Inc Recent Development Table 78. Glaxosmithkline plc Company Information Table 79. Glaxosmithkline plc Business Overview Table 80. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio Table 82. Glaxosmithkline plc Recent Development Table 83. MAP Pharmaceuticals，Inc Company Information Table 84. MAP Pharmaceuticals，Inc Business Overview Table 85. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 87. MAP Pharmaceuticals，Inc Recent Development Table 88. Merck & Co. Inc Company Information Table 89. Merck & Co. Inc Business Overview Table 90. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 92. Merck & Co. Inc Recent Development Table 93. QVAR Company Information Table 94. QVAR Business Overview Table 95. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. QVAR Asthma Reliever (Rescue) Medications Product Portfolio Table 97. QVAR Recent Development Table 98. Roche Holdings Ltd Company Information Table 99. Roche Holdings Ltd Business Overview Table 100. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio Table 102. Roche Holdings Ltd Recent Development Table 103. Sanofi-Aventis Company Information Table 104. Sanofi-Aventis Business Overview Table 105. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio Table 107. Sanofi-Aventis Recent Development Table 108. Schering-Plough Corp Company Information Table 109. Schering-Plough Corp Business Overview Table 110. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio Table 112. Schering-Plough Corp Recent Development Table 113. Sepracor, Inc Company Information Table 114. Sepracor, Inc Business Overview Table 115. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 117. Sepracor, Inc Recent Development Table 118. Theravance Inc Company Information Table 119. Theravance Inc Business Overview Table 120. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 122. Theravance Inc Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Asthma Reliever (Rescue) Medications Distributors List Table 126. Asthma Reliever (Rescue) Medications Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Asthma Reliever (Rescue) Medications Product Image Figure 2. Global Asthma Reliever (Rescue) Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Reliever (Rescue) Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Reliever (Rescue) Medications Sales (2021-2032) & (K Units) Figure 5. Global Asthma Reliever (Rescue) Medications Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Asthma Reliever (Rescue) Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Quick-Relief Medications Image Figure 9. Long-Term Control Medications Image Figure 10. Global Asthma Reliever (Rescue) Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Asthma Reliever (Rescue) Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2032) Figure 13. Global Asthma Reliever (Rescue) Medications Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Asthma Reliever (Rescue) Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2032) Figure 16. Adult Image Figure 17. Children Image Figure 18. Adolescent Image Figure 19. Global Asthma Reliever (Rescue) Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Asthma Reliever (Rescue) Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2032) Figure 22. Global Asthma Reliever (Rescue) Medications Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Asthma Reliever (Rescue) Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2032) Figure 25. North America Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Asthma Reliever (Rescue) Medications Sales Market Share by Country (2021-2032) Figure 27. U.S. Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Country (2021-2032) Figure 32. Germany Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Asthma Reliever (Rescue) Medications Sales Market Share by Country (2021-2032) Figure 39. China Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales Market Share by Country (2021-2032) Figure 47. Brazil Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Asthma Reliever (Rescue) Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Asthma Reliever (Rescue) Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Figure 58. North America Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Figure 60. Europe Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asthma Reliever (Rescue) Medications Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Asthma Reliever (Rescue) Medications Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-Relief Medications
  • Long-Term Control Medications
Applications
  • Adult
  • Children
  • Adolescent
Companies covered
  • AstraZeneca plc
  • Dulera
  • Genentech Inc
  • Glaxosmithkline plc
  • MAP Pharmaceuticals，Inc
  • Merck & Co. Inc
  • QVAR
  • Roche Holdings Ltd
  • Sanofi-Aventis
  • Schering-Plough Corp
  • Sepracor, Inc
  • Theravance Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Asthma Reliever (Rescue) Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Asthma Reliever (Rescue) Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Asthma Reliever (Rescue) Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Asthma Reliever (Rescue) Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Asthma Reliever (Rescue) Medications Market Dynamics
  1. 2.1 Asthma Reliever (Rescue) Medications Industry Trends
  2. 2.2 Asthma Reliever (Rescue) Medications Industry Drivers
  3. 2.3 Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges
  4. 2.4 Asthma Reliever (Rescue) Medications Industry Restraints
3 Asthma Reliever (Rescue) Medications Market by Manufacturers
  1. 3.1 Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Asthma Reliever (Rescue) Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Asthma Reliever (Rescue) Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Asthma Reliever (Rescue) Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Reliever (Rescue) Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Asthma Reliever (Rescue) Medications Manufacturers, Product Type & Application
  7. 3.7 Global Asthma Reliever (Rescue) Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Reliever (Rescue) Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Reliever (Rescue) Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Reliever (Rescue) Medications Tier 1, Tier 2, and Tier 3
4 Asthma Reliever (Rescue) Medications Market by Type
  1. 4.1 Asthma Reliever (Rescue) Medications Type Introduction
  2. 4.1.1 Quick-Relief Medications
  3. 4.1.2 Long-Term Control Medications
  4. 4.2 Global Asthma Reliever (Rescue) Medications Sales by Type
  5. 4.2.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
  7. 4.2.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2032)
  8. 4.3 Global Asthma Reliever (Rescue) Medications Revenue by Type
  9. 4.3.1 Global Asthma Reliever (Rescue) Medications Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
  11. 4.3.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2032)
5 Asthma Reliever (Rescue) Medications Market by Application
  1. 5.1 Asthma Reliever (Rescue) Medications Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.1.3 Adolescent
  5. 5.2 Global Asthma Reliever (Rescue) Medications Sales by Application
  6. 5.2.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
  8. 5.2.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2032)
  9. 5.3 Global Asthma Reliever (Rescue) Medications Revenue by Application
  10. 5.3.1 Global Asthma Reliever (Rescue) Medications Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
  12. 5.3.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2032)
6 Global Asthma Reliever (Rescue) Medications Sales by Region
  1. 6.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Asthma Reliever (Rescue) Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Asthma Reliever (Rescue) Medications Revenue by Region
  1. 7.1 Global Asthma Reliever (Rescue) Medications Revenue by Region
  2. 7.1.1 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Asthma Reliever (Rescue) Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Asthma Reliever (Rescue) Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Asthma Reliever (Rescue) Medications Revenue (2021-2032)
  8. 7.2.2 North America Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Asthma Reliever (Rescue) Medications Revenue (2021-2032)
  11. 7.3.2 Europe Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Asthma Reliever (Rescue) Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Asthma Reliever (Rescue) Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Asthma Reliever (Rescue) Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca plc
  2. 8.1.1 AstraZeneca plc Company Information
  3. 8.1.2 AstraZeneca plc Business Overview
  4. 8.1.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio
  6. 8.1.5 AstraZeneca plc Recent Developments
  7. 8.2 Dulera
  8. 8.2.1 Dulera Company Information
  9. 8.2.2 Dulera Business Overview
  10. 8.2.3 Dulera Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dulera Asthma Reliever (Rescue) Medications Product Portfolio
  12. 8.2.5 Dulera Recent Developments
  13. 8.3 Genentech Inc
  14. 8.3.1 Genentech Inc Company Information
  15. 8.3.2 Genentech Inc Business Overview
  16. 8.3.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio
  18. 8.3.5 Genentech Inc Recent Developments
  19. 8.4 Glaxosmithkline plc
  20. 8.4.1 Glaxosmithkline plc Company Information
  21. 8.4.2 Glaxosmithkline plc Business Overview
  22. 8.4.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio
  24. 8.4.5 Glaxosmithkline plc Recent Developments
  25. 8.5 MAP Pharmaceuticals，Inc
  26. 8.5.1 MAP Pharmaceuticals，Inc Company Information
  27. 8.5.2 MAP Pharmaceuticals，Inc Business Overview
  28. 8.5.3 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Portfolio
  30. 8.5.5 MAP Pharmaceuticals，Inc Recent Developments
  31. 8.6 Merck & Co. Inc
  32. 8.6.1 Merck & Co. Inc Company Information
  33. 8.6.2 Merck & Co. Inc Business Overview
  34. 8.6.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio
  36. 8.6.5 Merck & Co. Inc Recent Developments
  37. 8.7 QVAR
  38. 8.7.1 QVAR Company Information
  39. 8.7.2 QVAR Business Overview
  40. 8.7.3 QVAR Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QVAR Asthma Reliever (Rescue) Medications Product Portfolio
  42. 8.7.5 QVAR Recent Developments
  43. 8.8 Roche Holdings Ltd
  44. 8.8.1 Roche Holdings Ltd Company Information
  45. 8.8.2 Roche Holdings Ltd Business Overview
  46. 8.8.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio
  48. 8.8.5 Roche Holdings Ltd Recent Developments
  49. 8.9 Sanofi-Aventis
  50. 8.9.1 Sanofi-Aventis Company Information
  51. 8.9.2 Sanofi-Aventis Business Overview
  52. 8.9.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio
  54. 8.9.5 Sanofi-Aventis Recent Developments
  55. 8.10 Schering-Plough Corp
  56. 8.10.1 Schering-Plough Corp Company Information
  57. 8.10.2 Schering-Plough Corp Business Overview
  58. 8.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio
  60. 8.10.5 Schering-Plough Corp Recent Developments
  61. 8.11 Sepracor, Inc
  62. 8.11.1 Sepracor, Inc Company Information
  63. 8.11.2 Sepracor, Inc Business Overview
  64. 8.11.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio
  66. 8.11.5 Sepracor, Inc Recent Developments
  67. 8.12 Theravance Inc
  68. 8.12.1 Theravance Inc Company Information
  69. 8.12.2 Theravance Inc Business Overview
  70. 8.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio
  72. 8.12.5 Theravance Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Reliever (Rescue) Medications Value Chain Analysis
  2. 9.1.1 Asthma Reliever (Rescue) Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Reliever (Rescue) Medications Production Mode & Process
  6. 9.2 Asthma Reliever (Rescue) Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Reliever (Rescue) Medications Distributors
  9. 9.2.3 Asthma Reliever (Rescue) Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst